- Report
- May 2025
- 120 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- April 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- April 2025
- 120 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- April 2025
- 180 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- January 2026
- 286 Pages
Global
From €2247EUR$2,500USD£1,951GBP
- Report
- January 2026
- 291 Pages
Global
From €2247EUR$2,500USD£1,951GBP
- Report
- March 2026
- 200 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- January 2026
- 180 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 184 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 194 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 198 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 193 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 191 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 191 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 180 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 194 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 188 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more